Publisher
Public Library of Science (PLoS)
Reference27 articles.
1. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia;S Rogers;Ophthalmology,2010
2. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors;P Song;J Glob Health,2019
3. Retinal Vein Occlusions Preferred Practice Pattern((R)) Guidelines;JS Pulido;Ophthalmology,2016
4. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study;DM Brown;Ophthalmology,2011
5. European Medicines Agency. Lucentis® Summary of Product Characteristics. Novartis Pharma AG, Basel, Switzerland. 2016. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000715/WC500043546.pdf (Accessed on December 20, 2019). [Internet].
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献